Return to homepagePandemic Pact

Supervising and evaluating regional recovery and aftercare for persistent complaints after COVID-19.

  • Funded by Netherlands Organisation for Health Research and Development (ZonMW)
  • Total publications:0 publications

Grant number: 1.04303E+13

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2023
    2027

  • Funder

    Netherlands Organisation for Health Research and Development (ZonMW)

  • Principal Investigator

    dr. TJ Hoogeboom

  • Research Location

    Netherlands

  • Lead Research Institution

    Radboud Universitair Medisch Centrum

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Why are we doing this project? Good organization of care is an important condition for care that meets the needs of people with persistent complaints after COVID-19. What results does this project deliver? After the project, we understand how COVID care in the region can be personalized, affordable, widely accessible and effective. Why is this project important for patients/clients and their loved ones? One in eight people experience persistent complaints after COVID-19. Where someone lives determines what care they receive. With the lessons learned from this project, we hope to help healthcare providers and patients in the Netherlands organize healthcare as best as possible. How are we going to implement this project? We will follow various initiatives that aim to improve regional care for people with persistent complaints after COVID-19. With these initiatives we learn by sharing knowledge and experiences and merging the findings. We then share these findings with healthcare providers, policy makers and patients in the Netherlands.